Academy Community

Medications for Addiction Treatment Retention in Adults With Opioid Use Disorder – Rapid Evidence Review

The Agency for Healthcare Research and Quality commissioned a rapid evidence review (1.6MB) on the effectiveness of interventions, to promote a broader understanding of the published literature on MAT retention among adults with opioid use disorder (OUD). The study team searched MEDLINE and the Cochrane Library from February 12, 2009, through August 20, 2019, for systematic reviews (SRs) and randomized controlled trials (RCTs). They summarized evidence for six retention intervention types and reported the following key findings from 2 SRs and 39 primary studies:

  • Care setting interventions that initiated MAT in soon-to-be-released incarcerated patients improved retention following release.
  • Contingency management improved retention when combined with antagonist MAT but not with agonist forms of MAT. Applicability, however, may be limited due to implementation challenges.
  • Preliminary trials suggest that retention in MAT supported with health IT approaches may be no worse than in-person approaches.
  • Early studies suggest no difference in retention with XR-buprenorphine in either injectable or implant formulations compared with daily buprenorphine. Studies showed conflicting results with XR-naltrexone injection compared with daily buprenorphine.
  • The addition of psychosocial interventions did not improve retention; however, many studies included some form of counseling in the control groups, potentially obscuring evidence of effectiveness.

Behavioral Health Challenges Related to COVID-19

During late June 2020, 40 percent of U.S. adults reported struggling with mental health or substance use issues. Among those experiencing disproportionately worse behavioral health outcomes were racial and ethnic minorities, younger adults, essential workers, and unpaid adult caregivers.

A recent Study from from the Centers for Disease Control and Prevention, found that intervention and prevention efforts to address COVID-19-associated behavioral health conditions should be part of the public health response to the pandemic. Community-level efforts, including communication strategies, should target those at increased risk for psychological distress and unhealthy coping mechanisms.

National Academies Address Integrated Behavioral Health in Primary Care

The Forum on Mental Health and Substance Use Disorders of the National Academies of Science, Engineering, and Medicine (NASEM) hosted a virtual public workshop on primary care approaches to delivering essential components of care for people with mental health and substance use disorders. Due to COVID-19, the workshop was held virtually via webinars on June 3, July 29, and August 26, 2020. Among the workshop presenters were two members of the National Integration Academy Council (NIAC), Frank Verloin deGruy III, M.D., MSFM, Chair; and Parinda Khatri, Ph.D. These experts, along with the many others who participated, provided an excellent overview of how far integrated behavioral health in primary care has come. They also addressed pitfalls and obstacles that need to be addressed and suggested strategies for going forward.

The Forum on Mental and Substance Use Disorders was convened by NASEM’s Health and Medicine Division. Information on the workshop, as well as links to all associated materials, including videos of the webinars, and the report are available.

White Paper Commentary Summarizing Evidence from AHRQ-funded Reports on Telehealth

As part of healthcare transformation in response to the COVID-19 pandemic, telehealth has greatly expanded. Many see this rapid expansion of telehealth not only as a solution to the current problem, but also as “an innovation whose time has come.” Rapid legislative and regulatory changes to payment and privacy requirements have been implemented. Of particular note are the Centers for Medicare & Medicaid Services temporary waivers and new rules that expanded access to care and facilitated payment for a wider range of telehealth services, including various behavioral health services. Changes in State policy and payment have also been important to expanding the delivery of behavioral health care via telehealth.

AHRQ has produced a white paper commentary summarizing the evidence from AHRQ-funded reports on telehealth published in 2016 and 2019. This commentary identifies two high-level findings:

  • Telehealth is beneficial for specific uses and patient populations, and
  • The evidence of benefit was concentrated in specific uses.

Treatment of Stimulant Use Disorders: A SAMHSA Evidence-Based Resource

The Substance Abuse and Mental Health Services Administration (SAMHSA) has released a guide to support healthcare providers, systems, and communities seeking to treat stimulant use disorders. The guide describes relevant research findings, examines best practices, identifies knowledge gaps and implementation challenges, and offers useful resources with the goal of distilling this research into recommendations for practice.

Medication-Assisted Treatment for Opioid Use Disorder During COVID-19 and Beyond: Using the AHRQ Academy Playbook

Join the HRSA Center of Excellence for Behavioral Health Technical Assistance (COE for BHTA) for a webinar on medication-assisted treatment (MAT) for opioid use disorder (OUD) during COVID-19 and how the AHRQ Academy Playbook can support this work. Presenters will share:

  • Tips and strategies that health centers can use at each stage of implementation
  • Emerging treatment models
  • Technologies and challenges of managing poly-substance use
  • Resources included in the AHRQ Academy Playbook
  • A case study from a health center in Maine (Penobscot Community Health Care).

Register for this webinar today - new users will need to first create an account. HRSA-funded Federally Qualified Health Centers, Primary Care Associations, Health Center Controlled Networks, and National Training and Technical Assistance Partners, as well as health center look-alikes, are invited to register for this webinar.

New Grants - HRSA’s Addiction Medicine Fellowship Program

The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), recently awarded $20.3 million to 44 recipients, to train addiction specialists at facilities in high-need communities that integrate behavioral and primary care services. HRSA’s Addiction Medicine Fellowship (AMF) program builds on the Agency’s efforts to combat the opioid crisis, and the new AMF program will increase the number of fellows these programs can train.

For a list of June 2020 award recipients, visit https://bhw.hrsa.gov/grants/medicine/addiction/fellowship-awards-fy20

Institutional Strategies To Enhance the Well Being of Healthcare Workers during COVID-19

A recent commentary in the Annals of Internal Medicine addresses the negative physical and psychological effects of the COVID-19 pandemic on healthcare workers (HCWs). The authors share lessons learned from observations of HCWs during the SARS and H1N1 outbreaks and summarize possible best practices to help reduce adverse effects for HCWs and promote institutional resilience.

New Reports Examine Effectiveness and Harm of Pain Treatment

Check out three new AHRQ-funded reports that assess the effectiveness and harm of different kinds of chronic pain treatments. These systematic reviews present the current state of the science on treatments for the most common types of chronic pain.

Essential Care for Mental Health and Substance Use Disorder Patients

Register for an upcoming webinar series beginning on June 3 hosted by The National Academies of Sciences, Engineering, and Medicine. The first webinar will explore the landscape of evolving models of care, such as accountable care organizations, patient-centered medical homes, and collaborative care arrangements. The second webinar, will feature our very own Academy NIAC member Dr. Frank deGruy Dr. deGruy will highlight approaches to facilitate the delivery of essential components of care for people with mental health and substance use disorders in primary care settings.

COVID-19 - SAMHSA Resource: Taking care of your behavioral health

The Substance Abuse and Mental Health Services Administration (SAMHSA) has issued tips on how to maintain your mental health and support yourself and loved ones during social distancing, quarantine, and isolation. You can also find additional resources for help during this crisis:
https://integrationacademy.ahrq.gov/news-and-events/resources/covid-19-a...

Guidance for People Who Use Substances on COVID-19

Did you know that people who use drugs are at higher risk of getting COVID-19 because of their weakened immune system? The Yale University School of Medicine has released Guidance for People Who Use Substances on COVID-19. Take a look. This resource emphasizes that harm reduction can help individuals reduce their risk of getting sick, and provides helpful tips for planning ahead.
https://integrationacademy.ahrq.gov/news-and-events/resources/covid-19-h...

**COVID-19 and Behavioral Health Resources

Visit the Academy portal homepage and access the latest resources for COVID-19 and its impact on behavioral health and primary care.

NEW ACADEMY RELEASE: Have you seen the new MAT for OUD tip sheet?

The AHRQ Academy has developed “6 Tips from the MAT for OUD Playbook,” a downloadable PDF infographic with a list of tips on things to avoid when implementing MAT for OUD services in primary care settings. Access the tip sheet here: https://integrationacademy.ahrq.gov/sites/default/files/ahrq-whatnottodo...

Have you browsed the MAT Tools & Resources collection?

The AHRQ Academy has developed the MAT tools and Resources a searchable database of tools and resources available to help those who offer or use MAT services. The tools can be filtered by a number of factors, including use, topic, format, audience, and terms of use. These tools can be used for opioid use disorder awareness and education, prevention of opioid use disorder, training and education about MAT, and implementation of MAT in Ambulatory Care. The tools and resources were identified through systematic searches within various published and grey literature. Although these tools are not specifically designed for rural primary care practice, they can be used in those settings, as well as a variety of other settings. Browse through the current collection and use the different filters and features to further specify your search.
https://integrationacademy.ahrq.gov/products/opioid-substance-use-resour...

Participate in National Rural Health Day on November 21, 2019

Since 2010, HRSA has hosted National Rural Health Day to highlight the efforts of and collaborations in rural communities to address unique challenges in accessing and delivering healthcare services. On November 21, join HRSA, U.S. Department of Health and Human Services (HHS) Deputy Secretary Eric Hargan, and other HHS agencies for a special celebration via webcast.

Visit the Academy Portal to learn more about National Rural Health Day events. https://integrationacademy.ahrq.gov/news-and-events/news/participate-nat...

Welcome New Members to the Academy Community

If you’re new here – Welcome to the Academy Community!

We are glad that you’ve joined us. The Academy Community is a platform to connect, network, and share experiences. Feel free to use this platform to connect with others who share similar interests, subscribe to different groups that suit your needs, participate in what’s being discussed and share your opinions via polls, direct messaging, Q&A, and posts.The content of the community is searchable for ease of access. Use the various tools and filters to make the most out of your experience here.

Visit the About page to learn more about AHRQ Academy:
https://integrationacademy.ahrq.gov/about-ahrq-academy

FDA hosting a 1-day Public Meeting - Strategies to Improve Health Equity Amidst the Opioid Crisis on November 21

The Food and Drug Administration is a one-day public meeting entitled “Office of Minority Health and Health Equity Public Meeting on Strategies to Improve Health Equity Amidst the Opioid Crisis" on November 21 in Rockville, MD.

The purpose of this public meeting is to share information and obtain the public's perspectives on the current opioid crisis and how it specifically affects minority populations across the country, approaches to prevent and treat opioid use disorder, and emerging research as it relates to improving care for racial and ethnic minority, underrepresented, and underserved populations, and how FDA can support those efforts.

Register today!
https://www.eventbrite.com/e/public-meeting-strategies-to-improve-health...

NEWS FLASH: Intent to Publish Funding Opportunity for the Management of Opioids and Opioid Use Disorder in Older Adults

Intent to Publish Funding Opportunity for the Management of Opioids and Opioid Use Disorder in Older Adults from the Agency for Healthcare Research and Quality (AHRQ). Learn more about this opportunity on the Academy Portal https://integrationacademy.ahrq.gov/news-and-events/news/intent-publish-...

Recent study indicates that children and youth with special health care needs may be exposed to opioids at a twofold higher rate than the general pediatric population.

Recent study indicates that children and youth with special health care needs may be exposed to opioids at a twofold higher rate than the general pediatric population. To learn more about the results of this study and its potential implications, watch the brief video abstract about this study here: https://pediatrics.aappublications.org/content/143/6/e20182199

In this video, Dr. James Feinstein discusses the importance of developing evidence-based best practice guidelines for prescribing opioids in pediatric populations.